Pfizer Inc. Share Price

“Pfizer Inc., founded in 1849 by Charles Pfizer and Charles F. Erhart, is an American Biotechnology and Pharmaceutical giant. It is currently headquartered in New York City, United States with worldwide operations and distributions. To ensure that the medicinal and vaccine requirements of every patient and individual are met, Pfizer has been adopting a rigorous and scientific approach towards its supply chain. They now have a network of 58 manufacturing sites around the world under Pfizer Global Supply (PGS). To further expand its operations in the research and pharmaceutical sphere, it entered various merger and acquisitions deals with other players including Wyeth, Pharmacia, Warner-Lambert, Innopharma, etc. Its primary focus areas include internal medicine, rare diseases, vaccines, inflammation, immunology, oncology, and anti-infectives. They have major R&D platforms in the fields of gene therapy, precision medicine, biosimilars, medicinal sciences, and maternal immunizations. Pfizer Is traded under the ticker symbol of PFE. The financials of Pfizer are as follows: While Pfizer clocked a revenue of $41.908 billion for 2020, its net income amounted to $6985 million for the same period. Pfizer has made significant contributions in the fight against Covid-19 and has been successful in the early development of the Pfizer-BioNTech Vocid-19 vaccine. In 2020, Pfizer achieved the Top Employer Certification for the 5th year in the UK. Going by the revenue, Pfizer is the 4th largest pharmaceutical company globally and the 3rd largest in terms of market capitalization. It is currently traded in NYSE and other indices, including S&P 100, S&P 500, and Russell 1000 Index. Currently Pfizer Inc. has a market cap of $157.97 Billion. It has a P.E ratio of 20.42. The shares of Pfizer Inc. are trading at {current share price in dollars (in INR)}. ”